Lo H H, Brown P I, Rankin G O
Department of Pharmacology, Marshall University School of Medicine, Huntington, WV 25755-9310.
Toxicology. 1990 Aug;63(2):215-31. doi: 10.1016/0300-483x(90)90044-h.
Chlorinated anilines are widely used as chemical intermediates in the manufacture of numerous dyes, pesticides, drugs and industrial compounds. The purpose of this study was to examine the nephrotoxic potential of the six dichloroaniline (DCA) isomers in vivo and in vitro. In the in vivo studies, male Fischer 344 rats (4-8 rats/group) were administered a single, intraperitoneal injection of a DCA isomer (0.4, 0.8 or 1.0 mmol/kg) as the hydrochloride salt or given vehicle (0.9% saline, 2.5 ml/kg), and renal function monitored at 24 and 48 h. Renal effects induced by DCA were characterized by decreased urine volume, increased proteinuria, hematuria, modest elevations in blood urea nitrogen (BUN) concentrations, decreased accumulation of p-aminohippurate (PAH) by renal cortical slices, and no change or a slight decrease in kidney weight. Renal morphological changes were observed as proximal tubular necrosis with lesser effects on distal tubular cells and collecting ducts. Based on the overall effects on renal function and morphology, the decreasing order of nephrotoxic potential was found to be 3,5-DCA greater than 2,5-DCA greater than 2,4-, 2,6- and 3,4-DCA greater than 2,3-DCA. The ability for the DCA to induce nephrotoxicity correlated well with the lipophilic properties of the DCA isomers and Hammett constants (sigma) for the various chloro substitutions. In the in vitro studies, renal cortical slices from naive male Fischer 344 rats were co-incubated with a DCA isomer (0-10(-3) M) and PAH or tetraethylammonium (TEA). All DCA isomers decreased PAH and TEA accumulation at 10(-3) M DCA concentration in the media with 3,5-DCA inducing the largest decrease at this concentration. These results indicate that DCA are capable of altering renal function in vivo and in vitro and that 3,5-DCA possesses the greatest nephrotoxic potential in vivo and in vitro.
氯代苯胺在众多染料、农药、药物及工业化合物的制造中被广泛用作化学中间体。本研究的目的是检测六种二氯苯胺(DCA)异构体在体内和体外的肾毒性潜力。在体内研究中,雄性Fischer 344大鼠(每组4 - 8只)腹腔注射一次DCA异构体(0.4、0.8或1.0 mmol/kg)的盐酸盐,或给予赋形剂(0.9%生理盐水,2.5 ml/kg),并在24小时和48小时监测肾功能。DCA诱导的肾脏效应表现为尿量减少、蛋白尿增加、血尿、血尿素氮(BUN)浓度适度升高、肾皮质切片对对氨基马尿酸(PAH)的摄取减少,以及肾脏重量无变化或略有下降。观察到的肾脏形态学变化为近端肾小管坏死,对远端肾小管细胞和集合管的影响较小。基于对肾功能和形态的总体影响,发现肾毒性潜力的递减顺序为3,5 - DCA大于2,5 - DCA大于2,4 -、2,6 -和3,4 - DCA大于2,3 - DCA。DCA诱导肾毒性的能力与DCA异构体的亲脂性以及各种氯取代的哈米特常数(sigma)密切相关。在体外研究中,将未处理的雄性Fischer 344大鼠的肾皮质切片与DCA异构体(0 - 10⁻³ M)和PAH或四乙铵(TEA)共同孵育。在培养基中DCA浓度为10⁻³ M时,所有DCA异构体均降低了PAH和TEA的摄取,其中3,5 - DCA在此浓度下诱导的降低最大。这些结果表明DCA能够在体内和体外改变肾功能,并且3,5 - DCA在体内和体外具有最大的肾毒性潜力。